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Background: Left ventricular noncompaction(LVNC) is an echocardiographic(echo) finding increasingly identified in the pediatric population. The 
clinical course of LVNC is variable and no predictors of outcome have been identified.
Methods: A retrospective chart review was conducted of all LVNC patients(pts) identified from 1993 to present. Echos were reviewed by an 
independent observer to confirm diagnosis and parameters. Univariate and multivariate proportional hazards models were performed to identify 
predictors of the primary outcome of death or heart transplant.
Results: There were 50 pts identified with LVNC: 34 under the age of 1 year(yr), 7 between 1 and 10 yrs, and 9 greater than 10 yrs of age. A 
metabolic and/or genetic disorder(Met) was found in 12 pts. Associated congenital heart disease(CHD) occurred in 13 pts, 11 of which were septal 
defects(7 VSD and 4 ASD). Hemodynamic instability at presentation, defined as requiring mechanical circulatory support or IV inotropic therapy, 
occurred in 21 pts, and 26 pts presented with shortening fraction(SF) <20%. Maximal ratio of noncompacted to compacted myocardium(NC:C) 
was >2:1 in 40 pts. There were 26 pts who either died or had a transplant at a median 1.17 yrs after presentation(11 deaths, 15 transplants). Pts 
surviving >1 or >2 yrs had 75% and 92% overall survival. With univariate analyses, hemodynamic instability(p<0.001), SF(p<0.001), the presence 
of Met(p=0.045) and the lack of CHD(p=0.06) were associated with decreased survival. Age(p=0.25) and NC:C ratio(p=0.14) were not predictors 
of survival. With multivariate analyses, instability was the strongest independent predictor of survival(Hazard Ratio(HR) 7, 95% CI 2.8-17.6). Met(HR 
2.6, 95% CI 1.1-6) and CHD(HR 0.33, 95% CI 0.11-1) remained influential.
Conclusions: LVNC is recognized more in the younger population, however age is not a predictor of outcome. Pts that present with hemodynamic 
instability and/or SF<20% have worse transplant-free survival. Associated Met is a risk factor for poor outcome, while CHD is protective. Most poor 
outcomes occur within the first year after presentation, and therefore early listing for transplant may lead to lower mortality in this population.
